Streetbeat News

MRAI

Marpai Inc

Employees

marpai health is working at the intersection of healthcare and deep learning, the most advanced form of artificial intelligence. our mission is to predict and prevent costly events in healthcare for the benefit of patients, providers and payors.

Open

1.40

Mkt cap

22M

Volume

64K

High

1.62

P/E Ratio

-0.55

52-wk high

3.46

Low

1.20

Div yield

N/A

52-wk low

0.40

Marpai has decided to withdraw from the Nasdaq hearings process and will transition its trading to the OTCQX Market.

Portfolio Pulse from Benzinga Newsdesk

May 24, 2024 | 8:02 pm

Marpai (NASDAQ:MRAI) reported Q1 2024 earnings with a smaller loss per share of $(0.46) than expected, beating the $(0.49) estimate, but missed revenue forecasts with $7.385M against an $8.7M expectation. This represents a significant improvement in losses compared to last year but a decrease in sales.

Portfolio Pulse from Benzinga Newsdesk

May 09, 2024 | 8:36 pm

Marpai, Inc. has initiated a cost reduction program and subleased one of its properties, aiming to save $3 million annually and strengthen its financial position.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 10:11 am

Marpai, Inc. has announced the sale of $113.83 million in convertible notes, a financial move that could impact its liquidity and potentially its stock price.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 4:00 pm

Maxim Group analyst Allen Klee has upgraded Marpai (NASDAQ:MRAI) from Hold to Buy and set a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 4:21 pm

Marpai (NASDAQ:MRAI) reported a Q4 EPS loss of $(0.65), a 60.37% improvement from last year's $(1.64) loss. Quarterly sales were $8.71M, meeting analyst expectations and marking a 14.18% increase from the previous year.

Portfolio Pulse from Happy Mohamed

March 26, 2024 | 8:03 pm

Numerous companies are scheduled to report their earnings on March 26, 2024, with a mix of projected profits and losses across various sectors. Notable mentions include bluebird bio with an expected quarterly loss, Elbit Systems projecting earnings, and GameStop anticipated to report earnings. Other companies like McCormick & Co and TD Synnex are also expected to report significant earnings, while firms like AEye and Ouster are projected to report losses.

Portfolio Pulse from Benzinga Insights

March 26, 2024 | 8:47 am

Marpai (NASDAQ:MRAI) is scheduled to release its quarterly earnings report on 2024-03-26, with analysts expecting an EPS of $0.00. Investors are hopeful for positive guidance for the next quarter. Marpai's stock performance has been negative over the last year, with a 37.88% decrease. The company's past earnings have shown a trend of beating EPS estimates but with mixed impacts on stock price.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 4:05 pm

In Friday's intraday session, the insurance industry saw significant movements with Huize Holding, Root, Oxbridge Re Holdings, Maiden Holdings, Marpai, and Tian Ruixiang Holdings experiencing gains, while eHealth, Fanhua, Palomar Holdings, Arch Capital Group, Investors Title, and Waterdrop faced declines. Notably, Maiden Holdings' Q4 earnings were released three days ago.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 5:40 pm

Shares of companies in the financial sector are down due to market weakness after disappointing February PPI data.

Portfolio Pulse from Benzinga Newsdesk

March 14, 2024 | 7:53 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.